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Abstract
Background: As a dual response to the HIV epidemic and the high level of injecting drug use in Vietnam, the
Ministry of Health (MOH) initiated a pilot methadone maintenance therapy (MMT) program in Hai Phong and Ho
Chi Minh City (HCMC) in early 2009. The objectives of the pilot were to provide evidence on whether MMT could
be successfully implemented in Vietnam and scaled up to other localities.
Methods: A prospective study was conducted among 965 opiate drug users admitted to the pilot. Data on
demographic characteristics, sexual behaviors, substance use behaviors (including heroin use), and blood-borne
virus infection (HIV, hepatitis B, and hepatitis C) were collected at treatment initiation and then again at 3-, 6-, 9-,
12-, 18-, and 24-month intervals thereafter.
Results: Twenty-four months after treatment initiation, heroin use as measured by urine test or self-report had
reduced from 100 % of participants at both sites to 14.6 % in Hai Phong and 22.9 % in HCMC. When adjusted for
multiple factors in Generalized Estimating Equations (GEE) logistic regression modeling, independent predictors of
continued heroin use after 24 months of MMT in HCMC were the following: poor methadone adherence (adjusted
odds ratio (AOR) = 3.7, 95 % confidence interval (CI) 1.8–7.8); currently on antiretroviral treatment (ART) (AOR = 1.8, 95 %
CI 1.4–2.4); currently on TB treatment (AOR = 2.2, 95 % CI 1.4–3.4); currently experiencing family conflict (AOR = 1.6,
95 % CI 1.1–2.4); and currently employed (AOR = 0.8, 95 % CI 0.6–1.0).
For Hai Phong participants, predictors were the following: currently on ART (AOR = 2.0, 95 % CI = 1.4–3.0);
currently experiencing family conflict (AOR = 2.0, 95 % CI = 1.0–3.9); and moderate adherence to methadone
(AOR = 2.1, 95 % CI = 1.2–1.9). In Hai Phong, the percentage of participants who were employed had also
increased by end of study from 35.0 to 52.8 %, while in HCMC the level remained relatively unchanged,
between 52.2 and 55.1 %.
Discussion: Study findings were used in multiple fora to convince policymakers and the public on the
significant and vital role MMT can play in reducing heroin use and improving quality of life for individuals
and families. Four years after this study was completed, Vietnam had expanded MMT to 162 clinics in 44
provinces serving 32,000 patients.
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Background
Methadone maintenance therapy (MMT) using oral
methadone was first proposed as a favorable treatment
for relieving heroin addiction over 50 years ago and has
since been scaled up in numerous countries as an effect-
ive intervention for reducing heroin dependence and
increasing quality of life [1]. With the advent of the HIV
epidemic among people who inject drugs, evidence has
shown that methadone increases adherence to antiretro-
viral therapy [2] and decreases mortality among people
living with HIV [3]. MMT has also been shown to be
associated with significant reductions in risk behaviors,
e.g., injecting drugs, needle sharing, and having multiple
sex partners or exchanging of sex for drugs or money
[4]. In addition, MMT has been demonstrated to be a
cost-effective treatment in several studies [5]. These
findings as a whole point to MMT as an integral and
essential component of both drug treatment strategies
and HIV prevention and treatment strategies.
Since the early 1990s, the HIV epidemic in Vietnam
has been predominantly fueled by the sharing of needles
and other injecting equipment among people who inject
drugs (PWID), mostly heroin [6–10]. HIV prevalence
among this population remains as high as 40 % in many
locations [11]. It is estimated by 2010 that there were
more than 130,000 PWID nationwide in Vietnam [12],
though this may be a significant underestimation [13].
Key HIV-related risk behaviors among this population
include a continuing high frequency of injection, sharing
of used needles and syringes, and unprotected sex with
both regular and commercial sex partners [11, 14].
Efforts to improve drug and HIV prevention policies, the
provision of harm reduction services, and outreach to re-
habilitation services were then initiated in the early 2000s,
[15]. However, one significant barrier to this was that the
type of rehabilitation offered was predominantly a net-
work of compulsory rehabilitation centers throughout the
country that focused on a mixture of detoxification, labor,
and lectures with little evidence-based service and a sub-
sequent high rate of re-incarceration [16].
The next significant event was the MMT pilot discussed
here. It was based in part on the observed reduction in
heroin use and injection among drug users on MMT
already documented in many countries in previous de-
cades [17–20]. The objectives, again, were to provide evi-
dence that MMT could be successfully implemented in
Vietnam and scaled up to other localities.
In this paper, we examine the outcomes of this
pilot, including prevalence of drug use, factors that
predict continued drug use, methadone dosage pat-
terns, and social factors such as employment and so-
cial relationships, among patients enrolled in a cohort
study at six MMT outpatient clinics in Hai Phong
and Ho Chi Minh City (HCMC), Vietnam. We also
discuss both technical and policy implications using
findings of this analysis.
Methods
An observational prospective study was conducted
among a cohort of participants who were consecutively
enrolled in an MMT program in six clinics in Hai Phong
and HCMC, Vietnam from January to October 2009.
Under the Ministry of Health (MOH) regulations, people
with the following characteristics were eligible: they
must have been at least 18 years of age; they must have
presented with opiate addiction for at least 3 years or
more; and they must have voluntarily applied for MMT.
Additional inclusion criteria were that participants were
able to grant informed consent and had no other serious
medical conditions that required hospitalization or
extensive medical care.
A total of 965 patients enrolled in this study over the
initial 9 months. After 2 years, 751 participants had
completed the study and 214 had been lost to follow-up.
Among those who were lost to follow-up, 16 had died,
97 had stopped MMT, 38 had withdrawn from the study,
and 74 had been arrested. The absolute case number lost
to follow-up at 12 months was 113 and at 24 months
was 214, leaving 852 participants in the study at
12 months and 751 at the 24-month follow-up. The
study retention proportion was 88.3 % (852/965) at
12 months and 77.8 % (751/965) at 24 months. Total
study time was 20,058 person-months.
Each participant was followed up for 24 months, in-
cluding study visits at enrollment and then at intervals
of 3, 6, 9, 12, 18, and 24 months. At each visit, partici-
pants underwent an individual interview with a trained
interviewer using a structured questionnaire. Informa-
tion on treatment progress was also collected from
patient medical records. Urine samples were collected to
provide a biological marker of opiate use and partici-
pants were asked to provide 5-ml venous blood for
detection of HIV, hepatitis B, and hepatitis C at each
data collection interval.
The structured questionnaire for individual interviews
included questions about participants’ characteristics (at
baseline), drug use, sexual behaviors, living arrange-
ments, employment, quality of life, and legal status in-
cluding criminal activities. Questions on sexual and
injecting risk behaviors were adopted from standardized
questionnaires previously used for HIV/STI behavioral
surveillance in Vietnam. Questions on injecting behav-
iors included history of injecting and detoxification, drug
types and modes of use, frequency of use, and needle
sharing. Sexual behavior questions covered sexual his-
tory, types and numbers of sex partners, and condom
use. Timeframes of variables of interest depended on
intervals between visits (3 months in the first year and
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6 months in the second year). Questions were also asked
on drug use in the 30 days prior to interview.
Participants’ quality of life was measured using a
WHO module known as WHO QOL-BREF [21]. This
tool has been widely used in health research in Vietnam
and other countries [22, 23]. It includes 28 items meas-
uring four domains of health: physical, psychological, so-
cial, and environment. Data were then extracted from
patient clinical files, including assessment forms used in
counseling sections with pre-structured data collection
forms. Patients’ daily methadone doses were also taken
from methadone dispensing databases.
The markers for heroin use were then derived from
urinalysis. During treatment of patients, a series of urine
tests was conducted by the clinic randomly at least once
per month or by physician’s direction when drug use
was suspected. Urine tests were also conducted at base-
line, 3, 6, 9, 12, 18, and 24 months at study sites by
trained technicians. The study team then used Instant-
View Morphine (300) Urine Test (Dip-Strip) test kits
(ALFA Scientific designs Inc.) for detection of morphine
biomarkers.
To generate the variable of concurrent heroin use, a
study subject was defined as continuing illicit heroin use
if in the course of two intervals, they had at least one
positive urine test (by random testing, by physician’s de-
cision, or at initial interview) or if they self-reported
continued drug use in the behavioral section of the
interview questionnaire.
The study team used Abbott Determine ™ HBsAg test
kits for detecting HBsAg and SD Bioline HCV test kits
for identifying HCV antibodies, both in patient plasma.
Specimens were collected by a technician at study site
and transported to microbiology labs at preventive medi-
cine centers in HCMC and Hai Phong.
HIV tests were performed following standard HIV
diagnostic algorithms approved by the MOH. Screening
was performed using Genscreen Ultra HIV Ag/Ab
(Biorad, US) and then confirmed by rapid test (Deter-
mine HIV-1/2 (Alere, Japan)) and EIA test Murex HIV
Ag/Ab (Dia Sorin, UK). The testing was conducted by
lab technicians at provincial HIV/AIDS centers (PACs).
The lab and technicians were certified by the National
Reference Laboratory at the National Institute of
Hygiene and Epidemiology (NIHE). Data were entered at
study sites using Microsoft Access (Microsoft Inc, 2007),
and data cleaning was performed after each round of
study visits.
Data analyses were performed separately for respon-
dents in Hai Phong and HCMC. Descriptive analyses
were employed for participants’ social and behavioral
characteristics. Trend analysis using random effects
logistic regression was used to show changes in drug use
by treatment period at intervals of 3, 6, 9, 12, 18, and
24 months after enrollment. Univariate analysis was
then used to assess the association between heroin
use (dependent variable) and other independent
variables. Any independent variables that had a
statistically significant association with the dependent
variable (p value < 0.05) were included in the final model.
General estimating equation (GEE) logistic regression
with random effects was used to take into account the
fact that each participant was measured multiple times
in the study for both dependent and independent vari-
ables. The GEE regression-based approach allowed for
more comprehensive use of correlated data and for more
reliable estimates in the study of substance use [24]. Var-
iables significant from univariate analyses were added
into the models using a stepwise procedure.
The study protocol, informed consent, and data collec-
tion forms were reviewed and approved by the FHI 360
Protection of Human Subjects Committee in North
Carolina, USA, and by the Hanoi School of Public
Health in Vietnam.
Results
Demographic characteristics of study participants are
presented in Table 1. Patients had used heroin an aver-
age of 10 years prior to initiating MMT (9.7 years among
participants in Hai Phong and 9.6 years among partici-
pants in HCMC). More than 60 % of participants used
heroin two to three times per day and one-third used it
four times or more per day. At enrollment, 81.2 % of
participants in Hai Phong and 87 % in HCMC were
injecting. Just 15 % of participants in Hai Phong re-
ported having ever being in mandatory detoxification
centers, and 45.6 % of participants in HCMC reported
having been in these centers at least once.
At baseline, 26.6 % of participants in Hai Phong and
37.2 % in HCMC were HIV-positive (p < 0.01). The
prevalence of HBV was 11.8 % in Hai Phong and 20.6 %
in HCMC (p < 0.01). HCV prevalence was much higher
among study participants: 40 % in Hai Phong and 69.8 %
in HCMC (p < 0.01).
Figure 1 shows trends of concurrent heroin use among
study participants. Where any patient had at least one of
the following conditions in the 30 days prior to the study
visit, “heroin use” was confirmed: (1) they self-reported
drug use, (2) they tested positive for opiates in a urine
test conducted by a clinician, or (3) they tested positive
for opiates in a urine test conducted during a study visit.
The largest decreases in heroin use were observed in
the period between the enrollment visit (baseline) and
the 3-month visit. Among the entire body of participants
using heroin at initiation of MMT, only 34.6 % in Hai
Phong were still using it after 3 months, and in HCMC,
36.2 % of participants were still using after 3 months.
This trend continued to the 6-month visit as well, with
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19.4 % of participants in Hai Phong and 25.5 % in
HCMC still using heroin in the 30 days prior to the 6-
month follow-up interview. Then at the 24-month
follow-up, 22.9 % of participants in Hai Phong and
14.6 % of participants in HCMC were still using heroin.
Table 2 shows the trends in methadone, antiretroviral
treatment (ART), and tuberculosis (TB) treatment. After
3 months, the mean dosage of methadone among
patients in Hai Phong was 9.6 ml, and in HCMC,
this was 10.6 ml. There was a marked difference in
dosing between Hai Phong and HCMC: the mean
dosage among Hai Phong participants stabilized at
9.6 ml, where the mean among HCMC participants
had increased from 10.5 ml at 3 months to 11.6 ml
at 24 months. Adherence did decline in both cities:
18.4 % of participants reported missing one or two
doses in the first 3 months, and by 24 months, this
figure had increased to 41.4 % for the 6 months
prior to final study visit. Percentage of patients who
had missed three or four doses also increased from
1.0 % at 3 months to 3.7 % in the final 6 months.
The data further showed that in the final 6 months,
3.7 % of participants had missed doses for a continu-
ous 5 days or more.
Table 1 Characteristics of MMT participants at baseline (n = 965)
Hai Phong HCMC Total p value
% (n) % (n) % (n)
Gender
Male 98.1 (458) 92.0 (458) 94.9 (916) 0.000b
Female 1.9 (9) 8.0 (40) 5.1 (49)
Age—mean (SE) 34.4 (0.1) 30.1 (0.1) 32.3 (0.1) 0.000c
Under 20 2.8 (13) 1.0 (5) 1.9(18) 0.000d
20 to 25 10.3 (48) 15.7 (78) 13.1 (126)
25 to 29 19.1 (89) 45.9 (228) 32.9 (317)
30 or more 67.9 (317) 37.4 (186) 52.2 (503)
Education
No school 0.6 (3) 0.8 (4) 0.7 (7) 0.631d
Primary school 8.8 (41) 10.6 (53) 9.7 (94)
Secondary school 44.1 (206) 46.8 (233) 45.5 (439)
High school 42.2 (197) 38.0 (189) 40.0 (386)
College/university 4.3 (20) 3.8 (19) 4.0 (39)
Monthly income—mean in US$ (SE) 285.5 (11.2) 292.4 (13.8) 289.1 (8.9) 0.699c
Duration of drug use—mean in year (SE) 9.7 (0.2) 9.6 (0.2) 9.7 (0.1) 0.596c
Frequency of heroin use at baseline
Once per day 1.1 (5) 2.4 (12) 1.8 (17) 0.256b
2 to 3 times/day 62.9 (291) 63.6 (316) 63.2 (607)
4 times or more per day 36.1 (167) 34.0 (169) 35.0 (336)
Methods of administering drug in the 30 days prior to MMT enrollment
Injecting 81.2 (379) 87.0 (433) 84.2 (812) 0.014b
Inhaling 21.6 (101) 18.7 (93) 20.1 (194) 0.253b
Had ever been in state-operated drug rehabilitation centers (“06 centers”) 15.0 (70) 45.6 (227) 30.8 (297) 0.000b
Had had sex with regular partners 46.7 (218) 43.4 (216) 45.0 (434) 0.302b
Had had commercial sex in the previous 3 months 3.6 (17) 2.6 (13) 3.1 (30) 0.357b
Had a regular sex partner who was also PWID 7.5 (35) 14.5 (72) 11.1 (107) 0.001b
HIV-positive 26.6 (124) 37.2 (146)a 31.4 (270) 0.001b
Hepatitis B positive 11.8 (55) 20.6 (102) 16.3 (157) 0.000b
Hepatitis C positive 40.0 (187) 69.8 (346) 55.4 (533) 0.000b
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At baseline visit, 27.2 % of participants were on ART,
and by the end of month 24, this figure was 29.2 %. Not-
ably, the proportion of patients who were on ART was
higher in HCMC than it was in Hai Phong. At the end
of the study follow-up period, 43.3 % of the HIV-positive
patients in HCMC were receiving ARVs and 16 % of the
HIV-positive patients in Hai Phong were receiving them.
Employment status and family characteristics are then
presented in Table 3. In univariate analysis, factors that
were statistically associated with concurrent heroin use
Fig. 1 Trends in heroin use over time among participants
Table 2 Methadone and ART
Follow-up periods p value
0–3 months 4–6 months 7–9 months 10–12 months 13–18 months 19–24 months
(n = 930) (n = 900) (n = 871) (n = 852) (n = 802) (n = 751)
Mean methadone doses at study visits, in ml (SE)
Hai Phong 9.6 (0.2) 9.9 (0.2) 9.5 (0.2) 9.5 (0.3) 9.4 (0.3) 9.6 (0.3) 0.248a
HCMC 10.6 (0.2) 11.0 (0.3) 11.2 (0.3) 11.4 (0.3) 11.5 (0.4) 11.6 (0.4) 0.000a
Total 10.1 (0.1) 10.4 (0.2) 10.4 (0.2) 10.4 (0.2) 10.4 (0.2) 10.6 (0.3) 0.000a
Missed methadone dose for 1–2 days, in %
Hai Phong 19.5 23.6 30.7 41.1 48.4 47.7 0.000a
HCMC 17.3 22.0 26.5 28.1 33.8 34.7 0.000a
Total 18.4 22.8 28.6 34.6 41.3 41.4 0.000a
Missed methadone doses for continuous 3–4 days, in %
Hai Phong 1.3 0.9 1.8 1.9 2.2 3.4 0.009a
HCMC 0.6 0.9 1.4 0.7 1.0 4.1 0.000a
Total 1.0 0.9 1.6 1.2 1.6 3.7 0.000a
Missed methadone doses for a continuous 5 days or more, in %
Hai Phong 0.9 1.1 1.1 1.2 2.2 2.3 0.025a
HCMC 1.3 0.9 1.4 0.9 3.3 4.1 0.000a
Total 1.1 1.0 1.3 1.1 2.7 3.2 0.000a
ARV treatment, in %
Hai Phong 14.2 12.9 15.1 14.0 16.3 16.0 0.202a
HCMC 39.8 50.8 35.9 38.7 41.2 43.3 0.846a
Total 27.2 31.9 25.5 26.3 28.4 29.2 0.827a
aTest for trend
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were different for the two cities. In Hai Phong, they
included having conflict in the family (odds ratio (OR):
2.0; 95 % confidence interval (CI): 1.0 4.0), higher
methadone dosage (OR: 1.2; 95 % CI: 1.0–1.3), moderate
level of adherence to methadone treatment (OR: 1.5;
95 % CI: 1.2–1.8), and currently on ART (OR: 2.2; 95 %
CI: 1.5–3.1). In HCMC, more factors were found associ-
ated with concurrent heroin use among participants,
including both protective and risk factors. Protective fac-
tors included age (OR: 0.8; 95 % CI: 0.7–0.9) and being
employed full-time (OR: 0.7; 95 % CI: 0.6–0.9). Risk fac-
tors included having conflict in the family (OR: 1.9; 95 %
CI: 1.3–2.7), living with injecting family members (OR:
1.7; 95 % CI: 1.0–3.0), higher methadone dosage (OR:
1.2; 95 % CI: 1.1–1.3), level of adherence in follow-up
periods (for moderate adherence: OR: 1.5; 95 % CI:
1.2–1.9, for poor adherence: OR: 3.5; 95 % CI:1.7–
7.1), currently on ART (OR: 2.1; 95 % CI 1.6–2.9),
and currently on TB treatment (OR: 3.0; 95 % CI:
2.0–4.6) (Table 4).
In the final model for Hai Phong (Table 5), independ-
ent predictors of continued heroin use were the follow-
ing: currently on ART (adjusted odds ratio (AOR) = 2.0,
95 % CI = 1.4–3.0); currently experiencing family conflict
(AOR = 2.0, 95 % CI = 1.0–3.9); and moderate adherence
to methadone (AOR = 1.5, 95 % CI = 1.2–1.9).In the final
model for HCMC (Table 6), independent predictors of
continued heroin use were the following: currently on
ART (adjusted odds ratio (AOR) = 1.8, 95 % CI = 1.4–
2.4); currently experiencing family conflict (AOR = 1.6,
95 % CI = 1.1–2.4); and moderate adherence to metha-
done (AOR = 1.7, 95 % CI = 1.3–2.2).
In HCMC, independent predictors of continued heroin
use after 24 months of MMT were the following: poor
adherence (AOR = 3.7, 95 % CI 1.8–7.8); currently on
ART (AOR = 1.8, 95 % CI 1.4–2.4); currently on TB
treatment (AOR = 2.2, 95 % CI 1.4–3.4); currently ex-
periencing family conflict (AOR = 1.6, 95 % CI 1.1–2.4);
and currently employed (AOR = 0.8, 95 % CI 0.6–1.0).
Discussion
This study showed that MMT among people who
injected opioid drugs in the two cities led to improved
quality of life in terms of reduced drug use, higher levels
of employment, and reduced conflicts among families
and communities. The reductions in drug use found in
this study were comparable to that found in other stud-
ies [19, 25–29]. For example, in a recent cross-sectional
survey in nine provinces in China, 27 % of patients on
MMT were found to be still using opiates after 2 years
of MMT, compared to 20 % in this study [30].
The data also showed high prevalence of HIV among
MMT patients, at 26.6 % in Hai Phong and 37.2 % in
HCMC. Approximately half of the HIV-positive individ-
uals in the Hai Phong sample and almost all of the HIV-
positive individuals in the HCMC sample were on ART.
In both cities, patients who were on ART were more
likely to continue to use heroin compared to patients
not on ART. This may be due to the fact that ART al-
lows very ill patients to return to their previous lifestyles,
which in this case includes drug use. ART can also de-
crease methadone levels, and so, this may have also led
to increased recidivism to drug use among patients on
ART whose methadone dosages were not adjusted [31].
Table 3 Participants’ social characteristics and behaviors
Variables of
interest
Follow-up periods p value
0–3 months 4–6 months 7–9 months 10–12 months 13–18 months 19–24 months
(n = 930) (n = 900) (n = 871) (n = 852) (n = 802) (n = 751)
Percent of participants who were employed full-time and had stable monthly income (n)
Hai Phong 35.0 47.4 49.0 54.4 51.6 52.8 0.000a
HCMC 52.2 57.9 61.5 56.1 53.2 55.1 0.705a
Total 43.8 52.7 55.2 55.3 52.4 53.9 0.002a
Percent of participants who reported having conflict within their family
Hai Phong 2.0 3.8 2.8 2.3 0.7 0.8 0.005a
HCMC 17.3 3.1 4.2 2.6 6.1 3.9 0.000a
Total 9.8 3.4 3.4 2.5 3.4 2.3 0.000a
Percent of participants who reported having troubled relationships with family and community members
Hai Phong 2.4 3.1 1.8 2.3 2.2 1.8 0.394a
HCMC 9.7 9.8 5.3 5.9 6.1 4.4 0.001a
Total 6.1 6.4 3.6 4.1 4.1 3.1 0.001a
aTest for trend
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Several studies have shown the relationship between
methadone dosage and drug use behaviors, with higher
dosages associated with lower drug use [25, 32, 33].
However, in this study, no relationship between con-
current heroin use and methadone dosage was actu-
ally found. The results strongly suggest the need for
appropriate clinical guidelines for methadone dose
determination, however, particularly for patients who
are also on ART.
Similarly, the data showed that TB treatment also in-
creased the likelihood of continuing heroin use among
MMT patients in HCMC. This is in agreement with
findings from other studies, which show that rifampicin
reduces the half-life of methadone, that TB is common
among drug users who are HIV-positive, and that there
is a need to consider TB status and treatment in deter-
mining methadone dosage for patients [34, 35].
The findings that patients’ adherence to methadone
reduced with time in MMT and that poor adherence
increased the risk of relapse to drug use and the likeli-
hood of program withdrawal are supported by other
studies [36]. Furthermore, the associations between
adherence and heroin use, not only for those with poor
adherence but also for patients who missed just one or
two doses, strongly suggests that monitoring patient
adherence will help to monitor treatment failure. An
early warning system using data from methadone dis-
pensing may be useful to provide necessary and timely
support to concurrent heroin users. Future studies to
Table 5 Multivariate analysis of factors associated with
concurrent heroin use among MMT patients in Hai Phong
Adjusted ORa 95 % CI





ARV treatment (yes/no) 2.0 1.4–3.0
aAdjusted for age, gender, and methadone dose
Table 4 Bivariate analyses of risk factors for concurrent heroin use among MMT patients
Hai Phong HCMC
Unadjusted OR 95 % CI Unadjusted OR 95 % CI
Age (in 5-year units) 0.9 0.8–1.0 0.8 0.7–0.9
Gender (male is reference) 0.7 0.2–2.0 0.7 0.4–1.2
Ever been in an 06 center (yes/no) 1.0 0.7–1.5 1.1 0.8–1.5
Being employed full-time (yes/no) 1.1 0.9–1.4 0.7 0.6–0.9
Had problematic relation with family and/or community members (yes/no) 0.7 0.3–1.6 1.4 0.9–2.0
Had negative activities in family (yes/no) 2.0 1.0–4.0 1.9 1.3–2.7
Involved in criminal activities (yes/no) 1.2 0.6–2.2 1.6 0.6–4.2
Had PWID sex partners (yes/no) 1.2 0.4–3.6 1.3 0.9–1.8
Had PWID cohabitants (yes/no) 0.9 0.5–1.9 1.7 1.0–3.0
Methadone dosage (in 5-ml units) 1.2 1.0–1.3 1.2 1.1–1.3
Adherence to MMTa
Good adherence 1 – – –
Moderate adherence 1.5 1.2–1.8 1.5 1.2–1.9
Poor adherence 1.9 0.8–4.5 3.5 1.7–7.1
Current ART (yes/no) 2.2 1.5–3.1 2.1 1.6–2.9
Current TB treatment (yes/no) 0.9 0.1–5.9 3.0 2.0–4.6
aAdherence level was defined as the following: good: no dose missed; moderate: missed doses for 1 to 4 continuous days; poor: missed doses for 5 or more
continuous days
Table 6 Multivariate analyses of factors associated with
concurrent heroin use among MMT patients in HCMC
Adjusted ORa 95 % CI; p value
Age (in 5 year units) 0.8 0.7–0.9; 0.00
Being employed full-time (yes/no) 0.8 0.6–1.0; 0.05
Had conflict in the family (yes/no) 1.6 1.1–2.4; 0.03
Adherence to MMT
Good 1 -
Moderate 1.7 1.3–2.2; 0.00
Poor 3.7 1.8–7.8; 0.00
ART (yes/no) 1.8 1.4–2.4; 0.00
TB treatment (yes/no) 2.2 1.4–3.4; 0.00
aAdjusted for gender, ever been in a rehabilitation center, had a PWID
cohabitant or regular sex partner, problematic relationship with family or
community members, and methadone dosage
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understand patterns and reasons for non-adherence
among people who use heroin are thus needed.
In HCMC, the finding that patients who had full-time
employment and stable incomes also had a 20 % lower
likelihood of continuing heroin use may be interpreted
in two different ways: patients with stable jobs were
more likely to stop heroin, or heroin abstainers were
more likely to find a job. However, both interpretations
indicate that MMT is more successful when it is supple-
mented with other social support services to help heroin
users re-integrate into their communities.
Rates of HBV and HCV were both high in the sam-
ples in this study, with almost one in six infected
with HBV and over half infected with HCV. These
rates reinforce the need for both scaled-up HBV vac-
cination programs and scaled-up treatment manage-
ment of both HBV and HCV among people who
inject drugs (PWID), to monitor the onset and pro-
gression of liver disease and liver cancer.
The study had several limitations. Most notably, the
sample of individuals consisted of patients selected to
participate in a pilot program prior to a scaled-up re-
sponse. Qualitative evidence from health providers sug-
gests that these individuals may have been more
motivated, had higher incomes, and come from more
stable families than those in the general drug user
population.
Males were also predominant in this study (98.1 % of
the sample in Hai Phong and 92 % in HCMC), and this
reflects existing estimates that the drug use population
in Vietnam is over 95 % male [13]. Nevertheless, female
drug use remains a critical issue in the country because
it is highly related to sex work and HIV infection among
sex workers. Because of the low sample size of females
in this study, we were unable to make any conclusions
regarding their methadone use and related outcomes
among them. This remains a critical issue to address in
further research.
Furthermore, the loss to follow-up of a sizeable por-
tion of the cohort (22 %) also biased outcomes in an in-
determinate way. Of the 214 individuals who were lost
to follow-up, 74 of them had been arrested, however,
representing over one-third of those who did not con-
tinue with the study. Yet, it was not possible to deter-
mine whether they were arrested for drug use or other
reasons. However, the large number of arrests does sug-
gest that increased cooperation with law enforcement is
needed to ensure that PWID seeking and starting MMT
are encouraged to continue treatment.
Conclusions
The positive results of this study, combined with reports
from individual families on the positive impacts of
MMT on family stabilization and employment and
qualitative evidence showing reductions in crime in
areas where the pilot was located were the key in con-
vincing policymakers to consider MMT as feasible and
valuable, both for the control of HIV as well as drug use
reduction. Study results were presented to policymakers
at the provincial and national levels in numerous fora. A
national media campaign called Methadone is the Smart
Solution: Health for Patients, Hope for Families, and
Safety for Communities used results from the pilot, fam-
ily accounts, and positive community reactions to coun-
ter false perceptions of methadone and advocate for
broader national and provincial support. A national pol-
icy was finally signed in 2011 approving the scale-up of
MMT in all provinces, removing barriers to implementa-
tion and simplifying methadone licensing. By June 2015,
Vietnam had expanded MMT to 162 clinics in 44 prov-
inces serving 32,000 patients, with plans for continued
scale-up.
This rollout of MMT throughout the country fol-
lowing advocacy and policy-level interventions that
proactively used study results demonstrates the posi-
tive impacts of a carefully planned pilot of a sensitive
new intervention and data on its effectiveness, safety,
and impacts.
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